Home > Annual Financials > ZENOTECH LABORATORIES

ZENOTECH LABORATORIES Financial Statement Analysis
[BOM: 532039]

The Revenues of ZENOTECH LABORATORIES have increased by 16.02% YoY .
The Earnings Per Share (EPS) of ZENOTECH LABORATORIES has decreased by -47.66 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

ZENOTECH LABORATORIES Last 5 Annual Financial Results
[BOM: 532039]

StandaloneMar2023
Mar2022
Mar2021
Mar2020
Mar2019
Revenues ₹42 Cr₹37 Cr₹22 Cr₹26 Cr₹13 Cr
Expenses ₹22 Cr₹19 Cr₹16 Cr₹17 Cr₹17 Cr
Operating Profit (Excl OI) ₹21 Cr₹17 Cr₹6.38 Cr₹8.98 Cr₹-3.52 Cr
Other Income ₹1.08 Cr₹0.63 Cr₹0.41 Cr₹1.17 Cr₹4.71 Cr
Interest ₹0.11 Cr₹1.22 Cr₹1.55 Cr₹0.89 Cr₹0.12 Cr
Depreciation ₹7.17 Cr₹6.97 Cr₹6.46 Cr₹4.85 Cr₹4.20 Cr
Profit Before Tax ₹15 Cr₹9.90 Cr₹-1.22 Cr₹11 Cr₹-3.13 Cr
Profit After Tax ₹12 Cr₹22 Cr₹-1.22 Cr₹11 Cr₹-3.13 Cr
Consolidated Net Profit ₹12 Cr₹22 Cr₹-1.22 Cr₹11 Cr₹-3.13 Cr
Earnings Per Share (Rs)₹1.90₹3.63₹-0.20₹1.77₹-0.51
PAT Margin (%)27.3160.65-5.4141.42-24.00
ROE(%)15.1537.26-2.4824.35-7.73
ROCE(%)18.3915.260.4818.32-5.95
Total Debt/Equity(x)0.000.080.430.380.52

Key Financials

Market Cap : ₹ 402.9 Cr
Revenue (TTM) : ₹ 42.7 Cr
Net Profit(TTM) : ₹ 11.3 Cr
EPS (TTM) : ₹ 1.9
P/E (TTM) : 35.6

Industry Peers & Returns1W1M1Y
ZENOTECH LABORATORIES -3.6% -18.2% 27%
SUN PHARMACEUTICAL INDUSTRIES 3% 2.3% 68.2%
CIPLA 2.5% 0.4% 71.7%
DR REDDYS LABORATORIES -0.2% -4.9% 40.3%
ZYDUS LIFESCIENCES 5% 10.4% 109.1%
DIVIS LABORATORIES -1.6% -7% 23.8%
MANKIND PHARMA NA NA NA
TORRENT PHARMACEUTICALS 2.9% -2.2% 69%
LUPIN 2.8% 0% 147.8%


ZENOTECH LABORATORIES Revenues
[BOM: 532039]

Y-o-Y

16.02 %

5 Yr CAGR

34.33 %

Years Revenues % Change
Mar2023 ₹42 Cr
16.02
Mar2022 ₹37 Cr
62.91
Mar2021 ₹22 Cr
-13.74
Mar2020 ₹26 Cr
99.72
Mar2019 ₹13 Cr -


ZENOTECH LABORATORIES Operating Profit
[BOM: 532039]

Y-o-Y

18.57 %

5 Yr CAGR

Positive

Years Operating Profit % Change
Mar2023 ₹21 Cr
18.57
Mar2022 ₹17 Cr
173.68
Mar2021 ₹6.38 Cr
-28.95
Mar2020 ₹8.98 Cr
Positive
Mar2019 ₹-3.52 Cr -

Operating Margins
Y-o-Y

2.20 %

5 Yr CAGR

Positive

Years Operating Margin% % Change
Mar2023 48.8%
2.20
Mar2022 47.75%
67.96
Mar2021 28.43%
-17.62
Mar2020 34.51%
Positive
Mar2019 -26.99% -

ZENOTECH LABORATORIES Profit After Tax
[BOM: 532039]

Y-o-Y

-47.76 %

5 Yr CAGR

Positive

Years Profit After Tax % Change
Mar2023 ₹12 Cr
-47.76
Mar2022 ₹22 Cr
Positive
Mar2021 ₹-1.22 Cr
Negative
Mar2020 ₹11 Cr
Positive
Mar2019 ₹-3.13 Cr -

PAT Margins
Y-o-Y

-54.97 %

5 Yr CAGR

Positive

Years PAT Margin(%) % Change
Mar2023 27.31 %
-54.97
Mar2022 60.65 %
Positive
Mar2021 -5.41 %
Negative
Mar2020 41.42 %
Positive
Mar2019 -24 % -

ZENOTECH LABORATORIES Earnings Per Share (EPS)
[BOM: 532039]

Y-o-Y

-47.66 %

5 Yr CAGR

Positive

Years EPS % Change
Mar2023 ₹1.90
-47.66
Mar2022 ₹3.63
Positive
Mar2021 ₹-0.20
Negative
Mar2020 ₹1.77
Positive
Mar2019 ₹-0.51 -

ZENOTECH LABORATORIES Return on Capital Employed (ROCE)
[BOM: 532039]

Y-o-Y

20.51 %

5 Yr CAGR

Positive

Years ROCE % Change
Mar2023 18.39%
20.51
Mar2022 15.26%
3,079.17
Mar2021 0.48%
-97.38
Mar2020 18.32%
Positive
Mar2019 -5.95% -

ZENOTECH LABORATORIES Share Price vs Sensex

Current Share Price : ₹66.1
Current MarketCap: ₹ 402.9 Cr
Updated EOD on :Apr 18,2024

Share Price Returns(%) 1 Week 1 Month 1 Year
ZENOTECH LABORATORIES

-3.6%

-18.2%

27%

SENSEX

-2.9%

-0.4%

20%

ZENOTECH LABORATORIES related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about ZENOTECH LABORATORIES Financials


How the annual revenues of ZENOTECH LABORATORIES have changed ?

The Revenues of ZENOTECH LABORATORIES have increased by 16.02% YoY .

How the Earnings per Share (EPS) of ZENOTECH LABORATORIES have changed?

The Earnings Per Share (EPS) of ZENOTECH LABORATORIES has decreased by -47.66 % YoY .